1 The Procter & Gamble Company Regulation G Reconciliation of Non-GAAP Measures The following provides definitions of the non-GAAP measures used in Procter & Gamble's (“the Company”) July 29, 2026 earnings call, associated slides and other materials and the reconciliation to the most closely related GAAP measure. We believe that these non- GAAP measures provide useful perspective on underlying business trends (i.e., trends excluding non-recurring or unusual items) and results and provide a supplemental measure of year-on-year results. The non-GAAP measures described below are used by Management in making operating decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors, as they provide supplemental information about business performance and provide investors a view of our business results through the eyes of Management. Certain of these measures are also used to evaluate senior management and are a factor in determining their at-risk compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measure, but rather as supplemental information to our business results. These non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in method and in the items or events being adjusted. The Company is not able to reconcile its forward-looking non-GAAP cash flow and effective tax rate measures because the Company cannot predict the timing and amounts of discrete items such as acquisition and divestitures, which could significantly impact GAAP results. Note that certain columns and rows may not add due to rounding. The following measures are provided: 1. Organic sales growth — page 2 2. Core EPS and Currency-neutral Core EPS — page 3 3. Core gross margin and Currency-neutral Core gross margin — page 5 4. Core operating margin and Currency-neutral Core operating margin — page 5 5. Adjusted free cash flow and Adjusted free cash flow productivity — page 6 The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following items:  Incremental restructuring: The Company has historically had an ongoing level of restructuring activities of approximately $250 - $500 million before tax. In June 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve its cost structure and competitiveness. The Company incurred over half of the costs under this plan in fiscal 2026, with the remainder expected to be incurred in fiscal 2027. In the fiscal year ended June 30, 2024, the Company started a limited market portfolio restructuring of its business operations, primarily in certain Enterprise Markets, including Argentina and Nigeria, to address challenging macroeconomic and fiscal conditions. During the period ended September 30, 2024, the Company completed this limited market portfolio restructuring with the substantial liquidation of its operations in Argentina. Starting in 2012 through fiscal 2020, the Company had a strategic productivity and cost savings initiative that resulted in incremental restructuring charges. The adjustment to Core earnings includes the restructuring charges that exceed the normal, recurring level of restructuring charges.  Glad joint venture agreement: In January 2026, the Glad joint venture agreement between the Company and Clorox expired. Under the terms of the agreement, Clorox purchased the Company’s minority interest in the venture at fair market value for $476 million. This transaction was accounted for as a dissolution of the Glad joint venture business and the Company recorded an after-tax gain of $261 million.  Intangible asset impairment: In fiscal 2024, the Company recognized a non-cash, after-tax impairment charge of $1.0 billion ($1.3 billion before tax) to adjust the carrying value of the Gillette intangible asset acquired as part of the Company's 2005 acquisition of The Gillette Company. In fiscal 2019, the Company recognized a one-time, non-cash, after-tax charge of $8.0 billion ($8.3 billion before tax) to adjust the carrying values of the Shave Care reporting unit. This was comprised of a before and after-tax impairment charge of $6.8 billion related to goodwill and an after-tax impairment charge of $1.2 billion ($1.6 billion before tax) to reduce the carrying value of the Gillette indefinite-lived intangible assets.  Early debt extinguishment charge: In fiscal 2021 and 2018, the Company recorded after tax charges due to early extinguishment of certain long-term debt. These charges represent the difference between the reacquisition price and the par value of the debt extinguished.  Gain on dissolution of the PGT Healthcare partnership: The Company dissolved our PGT Healthcare partnership, a venture between the Company and Teva Pharmaceuticals Industries, Ltd (Teva) in the OTC consumer healthcare business, in fiscal 2019. The transaction was accounted for as a sale of the Teva portion of the PGT business and the Company recognized an after-tax gain on the dissolution.  Anti-dilutive impacts: The Shave Care impairment charges in fiscal 2019 caused certain equity instruments that are normally dilutive (and hence normally assumed converted or exercised for the purposes of determining diluted net earnings per share) to be -- 1 of 6 -- 2 anti-dilutive. Accordingly, for U.S. GAAP diluted earnings per share, these instruments were not assumed to be concerted or exercised. Specifically, certain of our preferred shares and share-based equity awards were not included in the diluted weighted average common shares outstanding. As a result of the non-GAAP Shave Care impairment adjustment, these instruments are dilutive for non-GAAP earnings per share.  Transitional impacts of the 2017 U.S. Tax Act: The U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “U.S. Tax Act”) in December 2017. This resulted in a net charge for the fiscal year 2018. The adjustment to Core earnings includes only this transitional impact. It does not include the ongoing impacts of the lower U.S. statutory rate on pre-tax earnings. We do not view the above items to be part of our sustainable results, and their exclusion from Core earnings measures provides a more comparable measure of year-on-year results. These items are also excluded when evaluating senior management in determining their at- risk compensation. Organic sales growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions and divestitures and foreign exchange from year-over-year comparisons. We believe this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis. This measure is also used in assessing the achievement of management goals for at-risk compensation. Core EPS and currency-neutral Core EPS: Core net earnings per share, or Core EPS, is a measure of diluted net earnings per common share (diluted EPS) adjusted for items as indicated. Currency-neutral Core EPS is a measure of the Company's Core EPS excluding the incremental current year impact of foreign exchange. Management views these non-GAAP measures as useful supplemental measures of Company performance over time. These measures are also used in assessing the achievement of management goals for at-risk compensation. Core gross margin and currency-neutral Core gross margin: Core gross margin is a measure of the Company's gross margin adjusted for items as indicated. Currency-neutral Core gross margin is a measure of the Company's Core gross margin excluding the incremental current year impact of foreign exchange. Management believes these non-GAAP measures provide a supplemental perspective to the Company’s operating efficiency over time. Core operating margin and currency-neutral Core operating margin: Core operating margin is a measure of the Company's operating margin adjusted for items as indicated. Currency-neutral Core operating margin is a measure of the Company’s Core operating margin excluding the incremental current year impact of foreign exchange. Management believes these non-GAAP measures provide a supplemental perspective to the Company’s operating efficiency over time. Adjusted free cash flow: Adjusted free cash flow is defined as operating cash flow less capital spending and excluding payments for the transitional tax resulting from the 2017 U.S. Tax Act. Adjusted free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. We view adjusted free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investments. Adjusted free cash flow productivity: Adjusted free cash flow productivity is defined as the ratio of adjusted free cash flow to net earnings excluding the gain from the dissolution of the Glad joint venture business. We view adjusted free cash flow productivity as a useful measure to help investors understand P&G’s ability to generate cash. This measure is used by management in making operating decisions, allocating financial resources and for budget planning purposes. This measure is also used in assessing the achievement of management goals for at-risk compensation. 1. Organic sales growth: Three Months Ended June 30, 2026 Net Sales Growth Foreign Exchange Impact Acquisition & Divestiture Impact/Other* Organic Sales Growth Beauty 6% (2)% —% 4% Grooming 1% (1)% —% —% Health Care 1% (2)% —% (1)% Fabric Care & Home Care 1% —% (1)% —% Baby, Feminine & Family Care (1)% (1)% —% (2)% Total Company 2% (1)% (1)% —% * Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales. -- 2 of 6 -- 3 Organic Sales Growth Fiscal Year Ended June 30, 2026 Net Sales Growth Foreign Exchange Impact Acquisition & Divestiture Impact/Other* Organic Sales Growth Grooming 4% (3)% —% 1% Total Company 3% (2)% —% 1% * Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales. Prior Quarters Total Company Net Sales Growth Foreign Exchange Impact Acquisition/ Divestiture Impact/Other* Organic Sales Growth Q3 FY 2026 7% (4)% —% 3% Q2 FY 2026 1% (1)% —% —% Q1 FY 2026 3% (1)% —% 2% Q4 FY 2025 2% —% —% 2% Q3 FY 2025 (2)% 2% 1% 1% Q2 FY 2025 2% —% 1% 3% Q1 FY 2025 (1)% 1% 2% 2% * Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales. Prior Fiscal Years Total Company Net Sales Growth Foreign Exchange Impact Acquisition/ Divestiture Impact/Other* Organic Sales Growth FY 2025 —% 1% 1% 2% FY 2024 2% 2% —% 4% FY 2023 2% 5% —% 7% FY 2022 5% 2% —% 7% FY 2021 7% (1)% —% 6% FY 2020 5% 2% (1)% 6% FY 2019 1% 4% —% 5% * Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures for all periods and rounding impacts necessary to reconcile net sales to organic sales. Guidance Total Company Net Sales Growth Combined Foreign Exchange & Acquisition/Divestiture Impact/Other* Organic Sales Growth FY 2027 (Estimate) +1% to +3% —% +1% to +3% * Combined Foreign Exchange & Acquisition/Divestiture Impact/Other includes foreign exchange impacts, the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales. 2. Core EPS and Currency-neutral Core EPS: Three Months Ended June 30 2026 2025 Diluted EPS $1.26 $1.48 Incremental restructuring 0.16 — Core EPS $1.43 $1.48 Percentage change vs. prior period Core EPS (3)% Currency impact to earnings (0.02) Currency-Neutral Core EPS $1.41 Percentage change vs. prior period Core EPS (5)% -- 3 of 6 -- 4 Core EPS and Currency-Neutral Core EPS Current and Prior Fiscal Years 2026 2025 2024 2023 2022 2021 2020 2019 2018 Diluted Net Earnings Per Common Share from Continuing Operations, attributable to P&G $6.62 $6.51 $6.02 $5.90 $5.81 $5.50 $4.96 $1.43 $3.67 Incremental restructuring 0.37 0.33 0.15 — — — 0.16 0.13 0.23 Glad joint venture agreement (0.11) — — — — — — — — Intangible asset impairment — — 0.42 — — — — 3.03 — Early debt extinguishment charge — — — — — 0.16 — — 0.09 Gain on dissolution of PGT Healthcare — — — — — — — (0.13) — Anti-dilutive impacts — — — — — — — 0.06 — Transitional impacts of the 2017 U.S. Tax Act — — — — — — — — 0.23 Core EPS $6.89 $6.83 $6.59 $5.90 $5.81 $5.66 $5.12 $4.52 $4.22 Core EPS growth vs prior year 1% 4% 12% 2% 3% 11% 13% 7% Currency Impact to Earnings (0.09) 0.02 0.23 0.55 0.11 0.04 0.15 0.35 Currency-Neutral Core EPS $6.80 $6.85 $6.82 $6.45 $5.92 $5.70 $5.27 $4.87 Percentage change vs. prior period Core EPS —% 4% 16% 11% 5% 11% 17% 15% Note – All reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction. Prior Quarters Note – All reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction. Guidance Total Company Diluted EPS Growth Impact of Incremental Non-Core Items* Core EPS Growth Impact of FX Currency-neutral Core EPS Growth FY 2027 (Estimate) +1% to +5% -1% to -2% —% to +3% —% —% to +3% * Includes the impact of the gain from the dissolution of the Glad joint venture business in fiscal 2026 and incremental non-core restructuring charges from the portfolio and productivity plan in fiscal 2026 and 2027. Q1 FY25 Q1 FY24 Q2 FY25 Q2 FY24 Q3 FY25 Q3 FY24 Q4 FY25 Q4 FY24 Q1 FY26 Q1 FY25 Q2 FY26 Q2 FY25 Q3 FY26 Q3 FY25 Diluted EPS $1.61 $1.83 $1.88 $1.40 $1.54 $1.52 $1.48 $1.27 $1.95 $1.61 $1.78 $1.88 $1.63 $1.54 Incremental restructuring 0.32 — — 0.02 — — — 0.13 0.04 0.32 0.10 — 0.07 — Glad joint venture agreement — — — — — — — — — — — — (0.11) — Intangible asset impairment — — — 0.42 — — — — — — — — — — Core EPS $1.93 $1.83 $1.88 $1.84 $1.54 $1.52 $1.48 $1.40 $1.99 $1.93 $1.88 $1.88 $1.59 $1.54 Percentage change 5% 2% 1% 6% 3% — 3% Currency Impact to Earnings (0.02) 0.02 0.03 (0.01) — (0.03) (0.05) Currency-Neutral Core EPS $1.91 $1.90 $1.57 $1.47 $1.99 $1.85 $1.54 Percentage change vs. prior period Core EPS 4% 3% 3% 5% 3% (2)% — -- 4 of 6 -- 5 3. Core gross margin and Currency-neutral Core gross margin: Three Months Ended June 30 2026 2025 Gross Margin 48.5% 49.1% Incremental restructuring 0.6% — Core Gross Margin 49.1% 49.1% Basis point change vs. prior year Core gross margin — Currency Impact to Margin — Currency-Neutral Core Gross Margin 49.1% Basis point change vs prior year Core gross margin — Fiscal Year Ended June 30 2026 2025 Gross Margin 50.2% 51.2% Incremental restructuring 0.5% — Core Gross Margin 50.7% 51.1% Basis point change vs. prior year Core gross margin (40) Currency Impact to Margin 0.1% Currency-Neutral Core Gross Margin 50.8% Basis point change vs prior year Core gross margin (30) 4. Core operating margin and Currency-neutral Core operating margin: Three Months Ended June 30 2026 2025 Operating Margin 18.6% 20.8% Incremental restructuring 0.9% — Core Operating Margin 19.5% 20.8% Basis point change vs. prior year Core operating margin (130) Currency Impact to Margin —% Currency-Neutral Core Operating Margin 19.5% Basis point change vs. prior year Core operating margin (130) Fiscal Year Ended June 30 2026 2025 Operating Margin 22.7% 24.3% Incremental restructuring 0.9% — Core Operating Margin 23.6% 24.3% Basis point change vs. prior year Core operating margin (70) Currency Impact to Margin 0.1% Currency-Neutral Core Operating Margin 23.7% Basis point change vs. prior year Core operating margin (60) -- 5 of 6 -- 6 5. Adjusted free cash flow and Adjusted free cash flow productivity (dollar amounts in millions): Three Months Ended June 30, 2026 Operating Cash Flow Capital Spending Adjusted Free Cash Flow Net Earnings Adjusted Free Cash Flow Productivity $5,131 $(1,023) $4,108 $3,081 133% Fiscal Year Ended June 30, 2026 Operating Cash Flow Capital Spending 2017 U.S. Tax Act Payments Adjusted Free Cash Flow Net Earnings Adjustments to Net Earnings(1) Net Earnings as Adjusted Adjusted Free Cash Flow Productivity $19,556 $(4,409) $688 $15,835 $16,144 $(261) $15,883 100% (1) Adjustments to Net Earnings relate to the gain from the dissolution of the Glad joint venture business in fiscal 2026. -- 6 of 6 --